Dermatitis could be suppressed as it develops

November 9, 2012 in Immunology

Dermatitis could be suppressed as it develops

Excessive immune reactions against the body's own skin cells can lead to painful and even chronic dermatitis. An international team of researchers at the MedUni Vienna, the MedUni Graz and the Salk Institute in California, led by Herbert Strobl, has now unencrypted the mechanism that contributes towards this unwanted autoimmune reaction being suppressed. This may in future lead to common conditions such as chronic allergic dermatitis or psoriasis being halted as they develop and treated.

The generally has two tasks: it needs to be able to respond effectively to viruses and bacteria, and also prevent reactions against the body's own cells. With every inflammation, but also during the natural regeneration process (renewal) of tissue, the body's own cells die. These represent a constant source of inflammation and are therefore eliminated by 'sentry cells' (macrophages and ) which act as the body's own waste disposal system.

These sentry cells are also charged with detecting and, with the help of T-cells in the lymph nodes, with triggering a in the form of inflammation against them. Says Strobl: "The sentry cells therefore carry out a constant balancing act between preventing inflammation caused by the body's own cells and triggering a desired inflammatory response to pathogens from outside the body."

In the study, which has now been published in the highly respected , the researchers from Vienna and Graz, in collaboration with colleagues from California, have been able to demonstrate that the sentry cells are programmed even during their development to detect the body's own , eliminate them and suppress any immune reaction to them.

They have also demonstrated that this mechanism is particularly important for the immune regulation of the skin, as well as the receptor responsible for this. The transmitter substance TGF-beta1 is synthesised in the epidermis and causes the presence of the Axl receptor on the cell surface of Langerhans cells (epidermal sentry cells) as well as on other skin cells. Says Strobl: "If this mechanism is literally switched off, dermatitis and excessive allergic reactions occur."  

Cortisone is currently the most important drug for the treatment of dermatitis – and although it is used effectively for many skin conditions, there is a demand for alternatives. The new findings regarding the mechanisms behind the development of dermatitis could, says Strobl, in future lead to the development of alternative medications that boost the receptor. This work has been financed by the Research Fund for Scientific Research in Austria (FWF).

More information: Bauer, T. et al., Identification of Axl as a downstream effector of TGF-β1 during Langerhans cell differentiation and epidermal homeostasis. JEM vol. 209 no. 11 2033-2047. doi: 10.1084/jem.20120493.

Journal reference: Journal of Experimental Medicine search and more info website

Provided by Medical University of Vienna search and more info website

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Related Stories
Relevant PhysicsForums posts

More news stories

Vaccine blackjack: IL-21 critical to fight against viral infections

(Medical Xpress)—Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.

Immunology created 8 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Fast-acting mothers' milk for healthier babies

Human breastmilk responds quickly to protect the child when there is an infection in mothers or babies, according to new international research led by The University of Western Australia.

Immunology created 9 hours ago | popularity 5 / 5 (1) | comments 0

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.

Immunology created May 20, 2013 | popularity 4.8 / 5 (25) | comments 8 | with audio podcast

Vitamin D could provide new and effective treatments for asthma

(Medical Xpress)—Scientists at King's College London have discovered that Vitamin D has the potential to significantly reduce the symptoms of asthma. The study, led by Professor Catherine Hawrylowicz from ...

Immunology created May 20, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Immune protein could stop diabetes in its tracks

Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been destroyed.

Immunology created May 20, 2013 | popularity 5 / 5 (5) | comments 0 | with audio podcast


When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs

Even while being dragged to its destruction inside a cell, a cancer-promoting growth factor receptor fires away, sending signals that thwart the development of tumor-suppressing microRNAs (miRNAs) before it's dissolved, researchers ...

Diabetes' genetic underpinnings can vary based on ethnic background, studies say

Ethnic background plays a surprisingly large role in how diabetes develops on a cellular level, according to two new studies led by researchers at the Stanford University School of Medicine.

Scientists discover cinnamon compounds' potential ability to prevent Alzheimer's

Cinnamon: Can the red-brown spice with the unmistakable fragrance and variety of uses offer an important benefit? The common baking spice might hold the key to delaying the onset of –– or warding off ...

Study reveals new mechanism for estrogen suppression of liver lipid synthesis

By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.

Flu vaccine also linked to narcolepsy in adults, study reports

Finnish researchers unveiled new data Thursday to link the Pandemrix flu vaccine to a higher risk of the sleeping disorder narcolepsy in adults.

Death rates decline for advanced heart failure patients, but outcomes are still not ideal

UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden ...